Figure 5From: The in vitroeffect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumoursTumour growth inhibition by gefitinib vs. gefitinib + oxaliplatin in a NSCLC. Legend The combination of oxaliplatin + gefitinib has a positive effect compared with single agent oxaliplatin which is inactive.Back to article page